Drug
14c Sep 380135
14c Sep 380135: highest development phase Phase 1, developed by Otsuka. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Otsuka
Trials
| Drug | Phase | Indication |
|---|---|---|
| 14C-SEP-380135 NCT07455084 | Phase 1 | Schizophrenia |
Latest
No recent events.
Follow 14c Sep 380135 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.